KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Arbutus Biopharma (ABUS) Receivables - Other (2016 - 2018)

Arbutus Biopharma's Receivables - Other history spans 8 years, with the latest figure at $128000.0 for Q1 2018.

  • For Q1 2018, Receivables - Other changed 0.0% year-over-year to $128000.0; the TTM value through Mar 2018 reached $128000.0, changed 0.0%, while the annual FY2017 figure was $128000.0, 0.0% changed from the prior year.
  • Receivables - Other for Q1 2018 was $128000.0 at Arbutus Biopharma, roughly flat from $128000.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.6 million in Q1 2015 and bottomed at $128000.0 in Q4 2015.
  • The 5-year median for Receivables - Other is $128000.0 (2015), against an average of $291411.8.
  • The largest annual shift saw Receivables - Other skyrocketed 287.14% in 2015 before it crashed 91.97% in 2016.
  • A 5-year view of Receivables - Other shows it stood at $538000.0 in 2014, then tumbled by 76.21% to $128000.0 in 2015, then changed by 0.0% to $128000.0 in 2016, then changed by 0.0% to $128000.0 in 2017, then changed by 0.0% to $128000.0 in 2018.
  • Per Business Quant, the three most recent readings for ABUS's Receivables - Other are $128000.0 (Q1 2018), $128000.0 (Q4 2017), and $128000.0 (Q3 2017).